相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Clozapine, GABA(B), and the Treatment of Resistant Schizophrenia
Z. J. Daskalakis et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
D1-Receptor Impact on Neuroplasticity in Humans
Michael A. Nitsche et al.
JOURNAL OF NEUROSCIENCE (2009)
The Dual-State Theory of Prefrontal Cortex Dopamine Function with Relevance to Catechol-O-Methyltransferase Genotypes and Schizophrenia
Daniel Durstewitz et al.
BIOLOGICAL PSYCHIATRY (2008)
L-dopa modulates motor cortex excitability in Alzheimer's disease patients
Alessandro Martorana et al.
JOURNAL OF NEURAL TRANSMISSION (2008)
Increased cortical inhibition in persons with schizophrenia treated with clozapine
Zafiris J. Daskalakis et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Reduced cortical inhibition in first-episode schizophrenia
T. Wobrock et al.
SCHIZOPHRENIA RESEARCH (2008)
Modulation of human motor cortex excitability by quetiapine
Berthold Langguth et al.
PSYCHOPHARMACOLOGY (2008)
Influence of cabergoline on motor excitability in patients with restless legs syndrome
A. Gorsler et al.
JOURNAL OF CLINICAL NEUROPHYSIOLOGY (2007)
Modulators in concert for cognition: Modulator interactions in the prefrontal cortex
Lisa A. Briand et al.
PROGRESS IN NEUROBIOLOGY (2007)
Cabergoline reverses cortical hyperexcitability in patients with restless legs syndrome
R. Nardone et al.
ACTA NEUROLOGICA SCANDINAVICA (2006)
Selective and nonselective benzodiazepine agonists have different effects on motor cortex excitability
B Mohammadi et al.
MUSCLE & NERVE (2006)
Dopaminergic modulation of long-lasting direct current-induced cortical excitability changes in the human motor cortex
MA Nitsche et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Dopaminergic enhancement of cognitive function
Mitul A. Mehta et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Silent period to transcranial magnetic stimulation: construction and properties of stimulus-response curves in healthy volunteers
VK Kimiskidis et al.
EXPERIMENTAL BRAIN RESEARCH (2005)
Amantadine inhibits NMDA receptors by accelerating channel closure during channel block
TA Blanpied et al.
JOURNAL OF NEUROSCIENCE (2005)
Cortical excitability in neuroleptic-naive first-episode schizophrenic patients
P Eichhammer et al.
SCHIZOPHRENIA RESEARCH (2004)
The principal features and mechanisms of dopamine modulation in the prefrontal cortex
JK Seamans et al.
PROGRESS IN NEUROBIOLOGY (2004)
Effect of antipsychotics on cortical inhibition using transcranial magnetic stimulation
ZJ Daskalakis et al.
PSYCHOPHARMACOLOGY (2003)
Relationship between lamotrigine oral dose, serum level and its inhibitory effect on CNS: insights from transcranial magnetic stimulation
F Tergau et al.
EPILEPSY RESEARCH (2003)
Intracortical inhibition and facilitation are impaired in patients with early Parkinson's disease:: a paired TMS study
M Bares et al.
EUROPEAN JOURNAL OF NEUROLOGY (2003)
Ketamine increases human motor cortex excitability to transcranial magnetic stimulation
V Di Lazzaro et al.
JOURNAL OF PHYSIOLOGY-LONDON (2003)
Short-interval paired-pulse inhibition and facilitation of human motor cortex: the dimension of stimulus intensity
TV Ilic et al.
JOURNAL OF PHYSIOLOGY-LONDON (2002)
Clinical and research methods for evaluating cortical excitability
G Abbruzzese et al.
JOURNAL OF CLINICAL NEUROPHYSIOLOGY (2002)
A transcranial magnetic stimulation study of the effects of olanzapine and risperidone on motor cortical excitability in patients with schizophrenia
PB Fitsgerald et al.
PSYCHOPHARMACOLOGY (2002)
Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation
ZJ Daskalakis et al.
ARCHIVES OF GENERAL PSYCHIATRY (2002)
Effect of apomorphine on cortical inhibition in Parkinson's disease patients: a transcranial magnetic stimulation study
M Pierantozzi et al.
EXPERIMENTAL BRAIN RESEARCH (2001)
Riluzole suppresses motor cortex facilitation in correlation to its plasma level - A study using transcranial magnetic stimulation
P Schwenkreis et al.
EXPERIMENTAL BRAIN RESEARCH (2000)
The dopamine D2 receptor agonist alpha-dihydroergocryptine modulates voltage-gated sodium channels in the rat caudate-putamen
C Neusch et al.
JOURNAL OF NEURAL TRANSMISSION (2000)